PL2058323T3 - Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC - Google Patents

Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC

Info

Publication number
PL2058323T3
PL2058323T3 PL09000315T PL09000315T PL2058323T3 PL 2058323 T3 PL2058323 T3 PL 2058323T3 PL 09000315 T PL09000315 T PL 09000315T PL 09000315 T PL09000315 T PL 09000315T PL 2058323 T3 PL2058323 T3 PL 2058323T3
Authority
PL
Poland
Prior art keywords
amino acid
given
peptide
tumour
bind
Prior art date
Application number
PL09000315T
Other languages
English (en)
Inventor
Claudia Trautwein
Hans-Georg Rammensee
Stefan Stevanovic
Toni Weinschenk
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Publication of PL2058323T3 publication Critical patent/PL2058323T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL09000315T 2004-05-25 2005-05-24 Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC PL2058323T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004026135A DE102004026135A1 (de) 2004-05-25 2004-05-25 An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP05752606A EP1761553B1 (de) 2004-05-25 2005-05-24 An mhc-moleküle bindende tumor-assoziierte peptide
EP09000315A EP2058323B1 (de) 2004-05-25 2005-05-24 An MHC-Moleküle bindende Tumor-assoziierte Peptide

Publications (1)

Publication Number Publication Date
PL2058323T3 true PL2058323T3 (pl) 2012-09-28

Family

ID=34970615

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05752606T PL1761553T3 (pl) 2004-05-25 2005-05-24 Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC
PL09000315T PL2058323T3 (pl) 2004-05-25 2005-05-24 Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL05752606T PL1761553T3 (pl) 2004-05-25 2005-05-24 Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC

Country Status (14)

Country Link
US (2) US8008431B2 (pl)
EP (2) EP2058323B1 (pl)
JP (2) JP4764874B2 (pl)
AT (1) ATE446310T1 (pl)
AU (1) AU2005247598B2 (pl)
CA (2) CA2777821C (pl)
CY (2) CY1109672T1 (pl)
DE (2) DE102004026135A1 (pl)
DK (2) DK1761553T3 (pl)
ES (2) ES2385532T3 (pl)
PL (2) PL1761553T3 (pl)
PT (2) PT1761553E (pl)
SI (2) SI1761553T1 (pl)
WO (1) WO2005116051A2 (pl)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004213A1 (en) * 2007-03-26 2009-01-01 Immatics Biotechnologies Gmbh Combination therapy using active immunotherapy
EP2155782A2 (en) 2007-03-26 2010-02-24 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP2167537A2 (en) 2007-07-03 2010-03-31 Dako Denmark A/S Compiled methods for analysing and sorting samples
PL3042914T3 (pl) * 2007-07-27 2019-01-31 Immatics Biotechnologies Gmbh Nowe immunogenne epitopy do immunoterapii
JP6008461B2 (ja) * 2007-07-27 2016-10-19 イマティクス バイオテクノロジーズ ゲーエムベーハー 神経細胞性脳腫瘍に対する新規免疫療法
AU2012216641B2 (en) * 2007-07-27 2015-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
WO2009039854A2 (en) 2007-09-27 2009-04-02 Dako Denmark A/S Mhc multimers in tuberculosis diagnostics, vaccine and therapeutics
JPWO2009054470A1 (ja) * 2007-10-25 2011-03-10 東レ株式会社 免疫誘導剤及びその用途
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
DK2105501T3 (da) * 2008-03-27 2015-11-23 Immatics Biotechnologies Gmbh Hidtil ukendt immunterapi mod neuronale tumorer og hjernetumorer
DK2113253T3 (da) * 2008-04-30 2010-07-19 Immatics Biotechnologies Gmbh Ny sammensætning af tumorassocierede peptider, der bindes til humant leukocyt-antigen (HLA) klasse I eller II molekyler, til vaccinebrug
NO2119726T3 (pl) 2008-05-14 2015-05-23
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
HUE027332T2 (en) 2008-08-05 2016-09-28 Toray Industries Cancer Detection Method
BRPI0911926A2 (pt) 2008-08-05 2020-08-18 Toray Industries, Inc composições farmacêuticas, anticorpos e usos de um anticorpo ou um fragmento do mesmo.
KR102009241B1 (ko) * 2008-08-05 2019-08-09 도레이 카부시키가이샤 면역 유도제
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
AU2016204708B2 (en) * 2008-10-01 2018-02-22 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors including neuronal and brain tumors
EP2172211B1 (en) 2008-10-01 2014-12-03 Immatics Biotechnologies GmbH Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
WO2010117010A1 (ja) 2009-04-10 2010-10-14 北海道公立大学法人札幌医科大学 腫瘍マーカーおよびその利用
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
HUE040012T2 (hu) 2010-02-04 2019-02-28 Toray Industries Gyógyászati ágens rák kezelésére és/vagy megelõzésére
BR112012018948B1 (pt) 2010-02-04 2021-12-14 Toray Industries, Inc Composições farmacêuticas, anticorpos, combinação farmacêutica, usos de uma composição farmacêutica, uso de um anticorpo e uso de uma combinação farmacêutica
EP2532365B1 (en) 2010-02-04 2016-05-04 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer
JP5906739B2 (ja) 2010-02-04 2016-04-20 東レ株式会社 癌の治療及び／又は予防用医薬組成物
JP5845899B2 (ja) 2010-02-04 2016-01-20 東レ株式会社 癌の治療及び／又は予防用医薬組成物
KR101801667B1 (ko) 2010-02-04 2017-11-27 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
GB201009222D0 (en) * 2010-06-02 2010-07-21 Immatics Biotechnologies Gmbh Improved cancer therapy based on tumour associated antigens derived from cyclin D1
IT1400874B1 (it) 2010-07-05 2013-07-02 Univ Degli Studi Genova Supporto planare avente una superficie ultrapiatta e dispositivo per la rivelazione di antigeni comprendente detto supporto planare.
MY170949A (en) * 2011-07-11 2019-09-20 Cancer Res Initiatives Foundation A peptide capable of binding with a human leukocyte antigen (hla) molecule, a cancer vaccine derived from said peptide and use of said cancer vaccine
RU2632645C2 (ru) 2012-02-21 2017-10-06 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или профилактики рака
DE102012105193B4 (de) * 2012-06-15 2014-04-03 Eberhard-Karls-Universität Tübingen Universitätsklinikum Stimulation der zellulären Immunantwort gegen das Epstein-Barr-Virus (EBV)
CN104497124B (zh) * 2013-12-23 2017-10-03 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497123B (zh) * 2013-12-23 2017-10-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
CN104497125B (zh) * 2013-12-23 2018-04-27 南方医科大学 Eps8抗肿瘤ctl表位肽及其应用
GB201505585D0 (en) 2015-03-31 2015-05-13 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carinoma (RCC) and other cancers
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201511546D0 (en) 2015-07-01 2015-08-12 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PE20230321A1 (es) 2015-07-01 2023-02-22 Immatics Biotechnologies Gmbh Nuevos peptidos y nuevas combinaciones de peptidos para el uso en la inmunoterapia contra el cancer de ovario y otros tipos de cancer
MY189596A (en) * 2015-07-15 2022-02-18 Immatics Biotechnologies Gmbh A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
GB201512733D0 (en) * 2015-07-20 2015-08-26 Genagon Therapeutics Ab Therapeutic agents for treating conditions associated with elevated GDF15
CN105859865B (zh) * 2016-05-05 2019-07-05 南方医科大学 一种基于Eps8-EGFR结合域的双重抗肿瘤多肽
CN106645677B (zh) * 2016-11-15 2019-08-09 恒瑞源正（上海）生物科技有限公司 体外检测肿瘤新生抗原特异性t细胞的方法、试剂盒以及肿瘤疫苗
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
EP4317432A3 (en) 2016-12-08 2024-04-17 Immatics Biotechnologies GmbH T cell receptors with improved pairing
GB201700567D0 (en) 2017-01-12 2017-03-01 Genagon Therapeutics Ab Therapeutic agents
US12258373B2 (en) 2018-12-17 2025-03-25 Immudex Aps Panel comprising Borrelia MHC multimers
WO2020243193A1 (en) 2019-05-28 2020-12-03 PAIGE.AI, Inc. Systems and methods for processing images to prepare slides for processed images for digital pathology
WO2022125504A1 (en) * 2020-12-07 2022-06-16 Iogenetics, Llc Bystander protein vaccines
EP4484442A1 (en) * 2023-06-29 2025-01-01 Uniwersytet Gdanski Tissue extracellular peptide patterns dedicated for generation of anti-cancer vaccines against salivary gland tumor, identification and isolation of salivary gland tumor specific t cells in humans

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840839A (en) * 1996-02-09 1998-11-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
US5955314A (en) * 1996-11-08 1999-09-21 Incyte Pharmaceuticals, Inc. Regulator of cell signaling
US6255055B1 (en) 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US7198920B1 (en) * 1999-01-29 2007-04-03 Corika Corporation HER-2/neu fusion proteins
US6274362B1 (en) 1999-02-04 2001-08-14 Millennium Pharmaceuticals, Inc. RGS-containing molecules and uses thereof
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
JP4097178B2 (ja) * 2000-10-03 2008-06-11 株式会社グリーンペプタイド 腫瘍抗原
US7009040B2 (en) * 2003-01-21 2006-03-07 Arius Research, Inc. Cancerous disease modifying antibodies
WO2002057420A2 (en) * 2001-01-18 2002-07-25 Human Genome Sciences, Inc. 50 human secreted proteins
US20040236091A1 (en) * 2001-03-28 2004-11-25 Chicz Roman M. Translational profiling
DE10225144A1 (de) * 2002-05-29 2003-12-18 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
WO2004015390A2 (en) * 2002-08-09 2004-02-19 Applera Corporation Lung cancer target proteins and use thereof
JP2006516089A (ja) * 2002-10-02 2006-06-22 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
EP1571909A4 (en) * 2002-10-03 2009-11-11 Idm Pharma Inc OPTIMIZED MULTIPOPOP CONSTRUCTS AND USES THEREOF
US7468254B2 (en) * 2003-01-21 2008-12-23 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP

Also Published As

Publication number Publication date
EP2058323A1 (de) 2009-05-13
CA2568254A1 (en) 2005-12-08
EP2058323B1 (de) 2012-05-16
CY1112984T1 (el) 2016-04-13
US8008431B2 (en) 2011-08-30
AU2011202473A1 (en) 2011-06-16
WO2005116051A3 (de) 2006-03-02
CA2568254C (en) 2016-04-19
JP2011224007A (ja) 2011-11-10
PT1761553E (pt) 2009-12-22
JP2008500033A (ja) 2008-01-10
WO2005116051A2 (de) 2005-12-08
CY1109672T1 (el) 2014-08-13
DK1761553T3 (da) 2010-02-01
AU2005247598B2 (en) 2011-06-02
PL1761553T3 (pl) 2010-07-30
ATE446310T1 (de) 2009-11-15
JP5182770B2 (ja) 2013-04-17
ES2385532T3 (es) 2012-07-26
US8242239B2 (en) 2012-08-14
US20100021441A1 (en) 2010-01-28
AU2005247598A1 (en) 2005-12-08
DK2058323T3 (da) 2012-08-06
SI1761553T1 (sl) 2010-01-29
DE102004026135A1 (de) 2006-01-05
CA2777821A1 (en) 2005-12-08
EP1761553A2 (de) 2007-03-14
PT2058323E (pt) 2012-07-10
CA2777821C (en) 2015-09-22
US20100029573A1 (en) 2010-02-04
SI2058323T1 (sl) 2012-08-31
ES2333804T3 (es) 2010-03-01
JP4764874B2 (ja) 2011-09-07
DE502005008379D1 (de) 2009-12-03
EP1761553B1 (de) 2009-10-21

Similar Documents

Publication Publication Date Title
PL2058323T3 (pl) Peptydy charakterystyczne dla nowotworów, wiążące się z cząsteczkami MHC
He et al. Facile synthesis of site-specifically acetylated and methylated histone proteins: reagents for evaluation of the histone code hypothesis
Yan et al. Synthesis of peptides and proteins without cysteine residues by native chemical ligation combined with desulfurization
Nagaike et al. Efficient microwave-assisted tandem N-to S-acyl transfer and thioester exchange for the preparation of a glycosylated peptide thioester
Michels et al. Acid-mediated prevention of aspartimide formation in solid phase peptide synthesis
UA98295C2 (ru) Опухолево-ассоциированный пептид, который неспецифически связывается с молекулами ii класса лейкоцитарного антигена человека (hla)
Hojo et al. Chemical synthesis of 23 kDa glycoprotein by repetitive segment condensation: a synthesis of MUC2 basal motif carrying multiple O-GalNAc moieties
Englebretsen et al. A novel thioether linker: chemical synthesis of a HIV-1 protease analogue by thioether ligation
MXPA04008077A (es) Anticuerpos ant-a° y su uso.
IL186802A0 (en) Oxyntomodulin analogues and compositions containing the same
MXPA06003474A (es) Agonistas de receptores de melanocortina.
CY1110723T1 (el) Σχετιζομενα με ογκους πεπτιδια δεσμευμενα σε μορια mhc
Sohma et al. Biomimetic synthesis of lispro insulin via a chemically synthesized “mini-proinsulin” prepared by oxime-forming ligation
WO2003093316A3 (en) Immunoglobulin-domain containing cell surface recognition molecules
WO2007018619A3 (en) Chimeric therapeutic agents
DK1066328T3 (da) Kimært protein, der indeholder en intramolekylær chaperon-lignende sekvens, og dets anvendelse til insulinproduktion
WO2004085461A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
IL173969A0 (en) Use of peptides derived from the a alpha or b beta chain of human of human fibrinogen for the treatment of shock
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
JP6643763B2 (ja) アゾール誘導体骨格を有するペプチドの製造方法
WO2007058267A8 (ja) 新規タンパク質及びそれをコードする遺伝子
CY1109904T1 (el) Προαγωγεας της il-18bp, η παρασκευη και χρηση του
WO2005072766A3 (en) Peptides that bind to hsp90 proteins
WO2006018450A3 (en) Pharmaceutically active insulin receptor-modulating molecules
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques